Safety assessment is an essential part of preclinical research to test the potential toxicity of new drug candidates before being exposed to the human body. At Creative Biolabs, our toxicity research segment is powered by multidisciplinary specialists and easy-to-access preclinical facilities all over the world, which will ensure your drug’s potential toxicity is best characterized. With rich preclinical drug development experience, you can always trust our team will reward you with reliable safety assessment results. Check more details NHP safety assessment services for preclinical drug development
